Daymark Wealth Partners’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,000
Closed -$103K 524
2024
Q2
$103K Hold
15,000
﹤0.01% 489
2024
Q1
$137K Sell
15,000
-10,000
-40% -$91K 0.01% 422
2023
Q4
$112K Hold
25,000
0.01% 394
2023
Q3
$78.5K Hold
25,000
0.01% 373
2023
Q2
$129K Buy
+25,000
New +$129K 0.01% 368